openPR Logo
Press release

Pharmacy OneSource Announces Free Webinar on Reducing Readmissions

02-02-2011 11:53 AM CET | Health & Medicine

Press release from: Pharmacy OneSource

Examining pharmacy strategies to reduce preventable readmissions
 
Bellevue, WA – Pharmacy OneSource, software-as-a-service provider of Sentri7, the real-time patient surveillance system, is pleased to announce a complimentary webinar presented by Steve Riddle, BS Pharm, BCPS, FASHP, in "Locking the Revolving Door of Readmissions: The Pharmacists Role in Keeping Patients Healthy, Happy and At Home."

Hospitals' avoidable readmission rates have come under close scrutiny by payers and policymakers because of the potential of high savings associated with them. According to a recent study, unplanned readmissions cost Medicare $17.4 billion in 2004. The study found that 20 percent of Medicare fee-for-service patients were readmitted within 30 days of discharge. In addition to having financial implications, avoidable readmissions are increasingly viewed as a quality issue by payers, health care organizations, and patients, with some research showing that readmission rates may be correlated with quality of care.

Tackling the issue of preventable readmissions will require improving care coordination between inpatient and outpatient care providers, engaging and educating the patient to manage their own care, expanding the use of technology to facilitate patient identification, risk stratification and to support care processes. While clearly a multidisciplinary effort, pharmacists can play important roles in reducing readmissions via provision of medication education and chronic disease management, medication reconciliation and ensuring use of evidence-based therapies.

Locking the Revolving Door of Readmissions: The Pharmacists Role in Keeping Patients Healthy, Happy and At Home
DATE: Wednesday, February 16, 2010
TIME: 1:00 PM - 2:00 PM EDT
WHERE: http://www.pharmacyonesource.com/webinars

About the Presenter: Steve Riddle, BS Pharm, BCPS, FASHP, currently serves as the VP of Clinical Affairs for Pharmacy OneSource. In this position he acts as a liaison between the company and the healthcare profession and guides product development to meet future trends in the health care market. Riddle is a representative for the ACCP on the Pharmacy Quality Alliance (PQA), serves on the CMS-appointed Hospital Outpatient Quality Measures Technical Expert Panel and is a member of the ASHP Quality Improvement Initiative Expert Panel. He has 24 years of pharmacy experience in a variety of clinical practice settings, including internal medicine, critical care, bone marrow transplant, renal transplant and acute and chronic cardiovascular care management. Riddle is a clinical assistant professor at the University Of Washington School Of Pharmacy and received his Doctorate of Pharmacy (PharmD) in 2010. Riddle was named a Fellow of ASHP in 2009 and received the WSPA Distinguished Leadership award in 2008 and the WSPA Innovative Pharmacy Practice award in 2004.

About Pharmacy OneSource (www.pharmacyonesource.com)
Pharmacy OneSource is healthcare’s #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services: Accupedia, Amplifi, MedBoard, Quantifi, ScheduleRx, Sentri7, Simplifi 797, and VeriForm.

Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacy OneSource Announces Free Webinar on Reducing Readmissions here

News-ID: 160857 • Views:

More Releases from Pharmacy OneSource

Richie's Specialty Pharmacy Selects Simplifi 797 for USP 797 Compliance
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Richie's Specialty Pharmacy, LLC has selected its Simplifi 797 software for achieving sterile compounding compliance. Simplifi 797 is a web-based application that automates, integrates and streamlines quality activities and documentation related to U.S. Pharmacopeia's Chapter 797 guidelines. The software manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance. "Simplifi
Pharmacy OneSource® Partners with CriticalPoint™ to Offer the Next Generation …
Bellevue, Washington – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Pharmacy OneSource® has released a new version of Simplifi 797®, a web-based quality assurance software for USP chapter 797 compounding compliance. The upgraded version of Simplifi 797 includes CriticalPoint's education program, which gives users unlimited access to 42 hours of ACPE-approved continuing education credits supporting compliance with USP Chapter . Lessons
Wolters Kluwer Health Unveils Integration between UpToDate and Sentri7
Bellevue, WA -- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that UpToDate's clinical knowledge system has been integrated with Sentri7 surveillance software by Pharmacy OneSource. This partnership of evidence-based clinical information through UpToDate and clinical patient surveillance from Sentri7 offers healthcare providers actionable information at the point of care to make better decisions in directing patient care. UpToDate synthesizes the most recent medical

More Releases for Pharm

Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the
Clopidol Market updates, demand analysis and expected growth forecast 2021-2027 …
The “Clopidol” Market report mainly studies the size, recent trends, and development status of the Clopidol market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain, and competitive landscape. Technological innovation and advancement will further enhance the performance of the product, making it more broadly used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for
Perphenazine Market Overall Study Report 2020-2027 | Players Sandoz, Actavis, Qu …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Perphenazine Market. The research report "Global Perphenazine Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Perphenazine market and the current trends that are likely to shape its future. Primary and secondary research methodologies have
Global Polygeline Injection Market Forecast 2018-2025 Abbott, Shengtai Pharm, BB …
A detailed market study on "Global Polygeline Injection Market" examines the performance of the Polygeline Injection market. It encloses an in-depth Research of the Polygeline Injection market state and the competitive landscape globally. This report analyzes the potential of Polygeline Injection market in the present and the future prospects from various angles in detail. The Global Polygeline Injection Market 2018 report includes Polygeline Injection market Revenue, market Share, Polygeline Injection industry